Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact.

ABSTRACT: Recombinant tissue-type plasminogen activator (tPA) is the fibrinolytic drug of choice to treat stroke patients. However, a growing body of evidence indicates that besides its beneficial thrombolytic role, tPA can also have a deleterious effect on the ischaemic brain. Although ageing influences stroke incidence, complications and outcome, age-dependent relationships between endogenous tPA and stroke injuries have not been investigated yet. Here, we report that ageing is associated with a selective lowering of brain tPA expression in the murine brain. Moreover, our results show that albumin D site-binding protein (DBP) as a key age-associated regulator of the neuronal transcription of tPA. Additionally, inhibition of DBP-mediated tPA expression confers in vitro neuroprotection. Accordingly,

ORGANISM(S): Mus musculus

SUBMITTER: Benoit Roussel 

PROVIDER: E-GEOD-9004 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress